Will Commission heed COCIR’s Comprehensive And Sometimes Radical Solutions To MDR Delays?

Industry’s timely compliance with the EU’s new medtech regulations is under threat. Will the European Commission consider potential solutions from COCIR as a persuasive factor for change?

Business Keyhole
Has COCIR Found the Elusive Solution to the MDR bottleneck problem?

It is the traditional summer break in Europe. But the volume of concerns being expressed by medtech players around the Medical Device Regulation’s 26 May 2024 compliance deadline is increasing.

The Hard Deadline

Manufacturers of medical devices and of many IVDs, including of new and legacy products, have a hard deadline of 26 May 2024 to comply with under the new EU Medical Device and IVD Regulations. Many are leaving compliance efforts so late that the size of the notified body bottlenecks will mean some will fail to be certified in time. Those that miss the cut-off will need to be removed from the market until they are declared compliant. That will be the case unless actions are taken by the commission to address this predicted scenario for many products.

Stakeholders are fearful that many products will remain uncertified under the new regulation’s still-tight timelines, often due to system failures...

Welcome to Medtech Insight

Create an account to read this article

More from Europe

Burden Is Too Heavy For Medtechs To Go It Alone On Complex Medtech AI Projects

 

Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System

 

A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.

More from Geography

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System

 

A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.

Commission Decision Launches Pediatric And Rare Disease Expert Group

 

A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.